Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Oncolytics Biotech (ONCY)
NASDAQ:ONCY
RESEARCH TOOLSreports
Oncolytics Biotech (ONCY) Stock Price & Analysis
946 Followers
ONCY Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.09 - $3.39
Previous Close$2.18
Volume202.51K
Average Volume (3M)753.50K
Market Cap
$158.31M
Enterprise Value$140.73M
Total Cash (Recent Filing)C$24.35M
Total Debt (Recent Filing)C$479.00K
Price to Earnings (P/E)-6.7
Beta1.02
Next Earnings
Nov 14, 2023EPS Estimate
-$0.08Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.33
Shares Outstanding73,368,847
10 Day Avg. Volume345,437
30 Day Avg. Volume753,495
Standard Deviation0.50
R-Squared0.06
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)9.80
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-6.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$7.76Price Target Upside255.96% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Oncolytics Biotech News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ONCY FAQ
What was Oncolytics Biotech’s price range in the past 12 months?
Oncolytics Biotech lowest stock price was $1.09 and its highest was $3.39 in the past 12 months.
What is Oncolytics Biotech’s market cap?
Currently, no data Available
When is Oncolytics Biotech’s upcoming earnings report date?
Oncolytics Biotech’s upcoming earnings report date is Nov 14, 2023 which is in 43 days.
How were Oncolytics Biotech’s earnings last quarter?
Oncolytics Biotech released its earnings results on Aug 14, 2023. The company reported -$0.088 earnings per share for the quarter, missing the consensus estimate of -$0.086 by -$0.002.
Is Oncolytics Biotech overvalued?
According to Wall Street analysts Oncolytics Biotech’s price is currently Undervalued.
Does Oncolytics Biotech pay dividends?
Oncolytics Biotech does not currently pay dividends.
What is Oncolytics Biotech’s EPS estimate?
Oncolytics Biotech’s EPS estimate is -$0.08.
How many shares outstanding does Oncolytics Biotech have?
Oncolytics Biotech has 72,368,800 shares outstanding.
What happened to Oncolytics Biotech’s price movement after its last earnings report?
Oncolytics Biotech reported an EPS of -$0.088 in its last earnings report, missing expectations of -$0.086. Following the earnings report the stock price went up 0.985%.
Which hedge fund is a major shareholder of Oncolytics Biotech?
Currently, no hedge funds are holding shares in ONCY
---
Oncolytics Biotech Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$7.76 (255.96% Upside)
$7.76 (255.96% Upside)
Blogger Sentiment
Bullish
ONCY Sentiment 100%
Sector Average 68%
Sector Average 68%
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.9%
Last 30 Days ▼ 3.1%
Last 30 Days ▼ 3.1%
News Sentiment
Neutral
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
71.65%
12-Months-Change
Fundamentals
Return on Equity
-98.25%
Trailing 12-Months
Asset Growth
-22.56%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Oncolytics Biotech
Oncolytics Biotech, Inc. engages in the development of immuno-oncolytic virus for the treatment of solid tumors and hematological malignancies. It offers a non-pathogenic, properietary isolate of the reovirus that induce selective tumor lysis, and promotes an inflamed tumor phenotype through innate and adaptive immune responses. The company was founded by Matthew C. Coffey and Bradley George Thompson on April 2, 1998 and is headquartered in Calgary, Canada.
---
---